chr17-6468237-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_031220.4(PITPNM3):āc.1878G>Cā(p.Gln626His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00375 in 1,613,304 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_031220.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PITPNM3 | NM_031220.4 | c.1878G>C | p.Gln626His | missense_variant | 14/20 | ENST00000262483.13 | NP_112497.2 | |
PITPNM3 | NM_001165966.2 | c.1770G>C | p.Gln590His | missense_variant | 13/19 | NP_001159438.1 | ||
PITPNM3 | XM_011524015.4 | c.1878G>C | p.Gln626His | missense_variant | 14/19 | XP_011522317.1 | ||
PITPNM3 | XM_011524016.4 | c.1878G>C | p.Gln626His | missense_variant | 14/18 | XP_011522318.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PITPNM3 | ENST00000262483.13 | c.1878G>C | p.Gln626His | missense_variant | 14/20 | 1 | NM_031220.4 | ENSP00000262483.8 | ||
PITPNM3 | ENST00000572795.1 | n.4384G>C | non_coding_transcript_exon_variant | 8/14 | 1 | |||||
PITPNM3 | ENST00000576664.5 | n.627G>C | non_coding_transcript_exon_variant | 5/11 | 1 | |||||
PITPNM3 | ENST00000421306.7 | c.1770G>C | p.Gln590His | missense_variant | 13/19 | 2 | ENSP00000407882.3 |
Frequencies
GnomAD3 genomes AF: 0.00209 AC: 318AN: 152232Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00160 AC: 401AN: 250184Hom.: 0 AF XY: 0.00158 AC XY: 214AN XY: 135342
GnomAD4 exome AF: 0.00392 AC: 5727AN: 1460954Hom.: 30 Cov.: 32 AF XY: 0.00373 AC XY: 2709AN XY: 726740
GnomAD4 genome AF: 0.00209 AC: 318AN: 152350Hom.: 0 Cov.: 33 AF XY: 0.00153 AC XY: 114AN XY: 74494
ClinVar
Submissions by phenotype
Cone-rod dystrophy 5 Pathogenic:1Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Apr 01, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | - - |
Pathogenic, flagged submission | literature only | OMIM | Jun 01, 2007 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | May 21, 2020 | A heterozygous missense variant was identified, NM_031220.3(PITPNM3):c.1878G>C in exon 14 of the PITPNM3 gene. This substitution is predicted to create a minor amino acid change from a glutamine to a histidine at position 626 of the protein; NP_112497.2(PITPNM3):p.(Gln626His). The glutamine at this position has low conservation (100 vertebrates, UCSC), and is not situated in a known functional domain (NCBI, PDB). In silico software predicts this variant to be tolerated (PolyPhen2, PROVEAN, MutationAssessor, FATHMM). The variant is present in the gnomAD population database at a global population frequency of 0.16% (455 heterozygotes, 0 homozygotes) with a European sub-population frequency of 0.31%. This variant has been previously reported with conflicting interpretations of pathogenicity in patients with cone-rod dystrophy (ClinVar, Reinis A. et al. (2013), Zhao, L. et al (2015), Khan, K. et al (2017), Jespersgaard, C. et al. (2019)). Based on information available at the time of curation, this variant has been classified as LIKELY BENIGN. - |
not provided Pathogenic:1Uncertain:1Benign:1
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 20, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Retinal dystrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg | Jan 01, 2022 | - - |
Retinitis pigmentosa Uncertain:1
Uncertain significance, no assertion criteria provided | research | Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet | Apr 01, 2018 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 19, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
PITPNM3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 14, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at